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ABSTRACT
The World Health Organization has emphasized that one of the most important questions to 
address regarding the covid-19 pandemic is to understand risk factors for disease severity. 
We conducted a brief review that synthesizes the available evidence and provides a judgment 
on the consistency of the association between risk factors and a composite end-point of 
severe-fatal covid-19. Additionally, we also conducted a comparability analysis of risk factors 
across 17 studies. We found evidence supporting a total of 60 predictors for disease severity, 
of which seven were deemed of high consistency, 40 of medium and 13 of low. Among the 
factors with high consistency of association, we found age, C-reactive protein, D-dimer, 
albumin, body temperature, SOFA score and diabetes. The results suggest that diabetes might 
be the most consistent comorbidity predicting disease severity and that future research 
should carefully consider the comparability of reporting cases, factors, and outcomes along 
the different stages of the natural history of covid-19.
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INTRODUCTION
More than 200 countries and territories have reported confirmed cases of the novel 
coronavirus disease covid-19, characterized as a pandemic by the World Health Organisation 
on April 7, 20201. As this global health emergency tests the resilience of health systems 
around the world, health care and public health practitioners are required to have high 
quality evidence to identify its most significant risks and prioritize resources where they 
are most needed. 
One of the most important questions to address the currently unfolding pandemic is “what 
are the risk factors for severe illness or death?”1,2.  Systematic reviews and meta-analysis 
paired with a standardised method to assess the quality of evidence are deemed to provide 
the best evidence by current standards3. For example, the GRADE evidence assessment 
focuses on comparing factors or outcomes across studies to provide an evidence synthesis. 
If researchers conduct a GRADE evaluation for covid-19 severity in the future, the time 
investment and internal validity of the assessment will be heavily influenced by the 
consistency of categorizations and reporting of cases, factors, and outcomes across studies.
Since scientific publications addressing the pandemic are being produced rapidly, 
including risk factor studies, summarizing and sharing such information is of paramount 
importance to support an efficient and rapid response. An early review of risk factor 
studies could also provide some insight on the undesirable heterogeneity of definitions 
and reporting that might affect later evidence evaluations. Therefore, we compiled a brief 
summary of the literature evaluating the risk factors for covid-19 disease severity with a 
two-fold purpose: (i) to provide healthcare and public health professionals with a reference 
list of the consistency of risk factors for covid-19 severity, and (ii) to inform researchers 
about the consistency of reporting in the available literature.
METHODS
We conducted a review to assess studies looking for risk factors of severity or death for 
covid-19, using a composite outcome of disease severity-fatality (CSF)4. Unstructured 
searches using the terms: “disease attributes,” “clinical findings,” “clinical features,” 
“clinical characteristic,” “novel coronavirus,” “covid-19,” “SARS-Cov-2,” “fatality,” “fatal,” 
“death,” “mortality,” “severity,” “disease severity,” “predictor,” and “risk factor” were 
performed to identify articles written in English available on PubMed, Scopus and 
MedRxiv. Articles were selected for the review if they included a comparison between 
non-severe and CSF cases according to the categorization of severity in each article. 
After completing article selection, we assessed the consistence of statistically significant 
associations for a particular risk factor by classifying it as high, medium, and low, 
following two criteria: (i) a positive difference in the total number of studies reporting 
statistical significance dissimilarities between non-severe and CSF, minus the number 
of studies without statistical significance for the same factor, and, (ii) the reporting of 
statistically significant estimates when performing multivariate statistics. The consistency 
of association was categorized as high (both criteria were met), medium (one criterion), 
low (none). Additionally, we assessed heterogeneity by comparing the terminology, units, 
statistical descriptions, and cut-off points of each risk factor and reported the highest 
comparable (hc) number across studies. We then subtracted the total of studies including 
the risk factor by the hc number across the sample (Table).  
RESULTS
We identified a total of 17 studies, with most of them relying on a retrospective 
cross-sectional design and reporting data using descriptive statistics. Only three studies 
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Table. Summary of risk factors associated with covid-19 severity and evaluation of reporting consistency
RISK 
FACTORS





(p < 0.05) 
- total  
(p > 0.05)
Results of  




All studies (n) 




% of  
p < 0.05 studies 
supporting a 
value direction 
or the presence 
of the risk factor
Studies  










Zhang et al.6 (19) 
Wang et al.7 (138) 
Tian et al.8 (262) 
Liu et al.9 (109) 
Liu et al.10 (78)
Li et al.11 (84) 
Caramelo et al.12 
(72314) 
Tang et al.13 (183) 
Ruan et al.14 (150) 
Zhou et al.15 (191) 
Wu et al.16 (201)
100% - ↑ Huang et al.
17  
(41)
Guan et al.18 
(1099) 
Yang et al.19 (52)
Young et al.20 (18) 




Liu et al.10 
≥ 60: OR 8.5 
95% CI 1.6 - 44.8 
 
Caramelo et al.12  
50-59: OR 6.7  
95% CI 2.9 - 15.2 
 
≥ 80: OR 86.6  
95% CI 32.6 - 
202.4 
 
Zhou et al.15  
NA: OR 1.1  
95% CI 1.0 - 1.2
●●●
12 






Zhang et al.6 (19) 
Li et al.11 (84) 
Liu et al.10 (78) 
Liu et al.9 (109) 
Ruan et al.14 (150) 
Wu et al.16 (201)
100% - ↑ 0
Young et al.20 (18) 
Guan et al.18 
(1099)
6
Liu et al.10 
> 8.2 mg/L: OR 
10.5 
95% CI 1.2 - 34.7
●●●
6 






Tang et al.13 (183) 
Huang et al.17 (41) 
Zhang et al.6 (19)
Wang et al.7 (138) 
Liu et al.9 (109) 
Zhou et al.15 (191) 
Wu et al.16 (201)




Zhou et al.15  
> 1 μg/mL: OR 
18.42  
95% CI 2.6 - 128.5
●●●
7 





Liu et al.10 (78) 
Huang et al.17 (41) 
Ruan et al.14 (150) 
Zhou et al.15 (191) 
Wu et al.16 (201)
100% - ↓ 0 0 5
Liu et al.10 
< 40 g/L: OR 7.4 
 95% CI 1.1 - 50.0
●●●
4 





Huang et al.17 (41) 
Li et al.11 (84) 
Liu et al.10 (78) 
Wu et al.16 (201)
75% - ↑ Tian et al.8 (262)
Guan et al.18 
(1099) 
Young et al.20 (18)
3
Liu et al.10 
≥ 37.3°: OR 8.9 
 95% CI 1.0 - 78.1
●●●
4 







Liu et al.9 (109) 
Zhou et al.15 (191) 100% - ↑ 0 0 2
Zhou et al.15  
NA: OR 5.7  
95% CI 2.6 - 12.2
●●●
2 





Caramelo et al.12 
(72314) 
Li et al.11 (84) 
Wang et al.7 (138) 
Liu et al.9 (109) 
Zhou et al.15 (191) 
Wu et al.16 (201)
100% - 
Presence
Huang et al.17 (41) 
Zhang et al.6 (19) 
Liu et al.10 (78) 
Ruan et al.14 (150)




Yang et al.19 (52)
2
Caramelo et al.12  
Diabetes: OR 9.0  
95% CI 7.4 - 11.3
●●●
13 






Zhang et al.6 (19) 
Li et al.11 (84) 
Wang et al.7 (138) 
Huang et al.17 (41)
Liu et al.9 (109) 
Ruan et al.14 (150) 
Wu et al.16 (201) 
Zhou et al.15 (191)
100% - ↓ Yang et al.
19 (52) 
Liu et al.10 (78)
Young et al.20 (18) 
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Table. Summary of risk factors associated with covid-19 severity and evaluation of reporting consistency. Continuation
Dyspnea
Li et al.11 (84) 
Huang et al.17 (41) 
Tian et al.8 (262) 
Wang et al.7 (138) 
Ruan et al.14 (150) 
Wu et al.16 (201)
100% - 
Presence
Zhang et al.6 (19)
Yang et al.19 (52) 
Guan et al.18 
(1099) 
Young et al.20 (18)
5 NA ●●○
10 






Huang et al.17 (41) 
Wang et al.7 (138) 
Liu et al.9 (109) 
Ruan et al.14 (150) 
Zhou et al.15 (191) 
Wu et al.16 (201) 
Zhang et al.6 (19)
100% - ↑ Li et al.
11 (84)
Liu et al.10 (78)
Guan et al.18 
(1099) 
Young et al.20 (18)
5 NA ●●○
8 






Li et al.11 (84) 
Wang et al.7 (138) 
Huang et al.17 (41) 
Liu et al.9 (109) 
Zhou et al.15 (191)











Wang et al.7 (138) 
Huang et al.17 (41) 
Liu et al.9 (109) 
Zhou et al.15 (191) 
Wu et al.16 (201)
100% - ↑ Ruan et al.14 (150)
Young et al.20 (18) 










Wang et al.7 (138) 
Huang et al.17 (41) 
Ruan et al.14 (150) 
Zhou et al.15 (191)
100% - ↑ 0 0 4 NA ●●○
3 







Huang et al.17 (41) 
Tang et al.13 (183) 
Zhou et al.15 (191) 
Wu et al.16 (201)
100% - ↑ Wang et al.7 (138) Yang et al.19 (52) 3 NA ●●○
5 







Ruan et al.14 (150) 
Liu et al.9 (109) 
Wang et al.7 (138)
100% - ↑ 0 0 3 NA ●●○
3 






Ruan et al.14 (150) 
Wang et al.7 (138) 
Huang et al.17 (41) 
Wu et al.16 (201)
100% - ↑ Liu et al.9 (109)
Yang et al.19 (52) 









Ruan et al.14 (150) 
Zhou et al.15 (191) 
Wu et al.16 (201)
100% - ↑ 0 0 3 NA ●●○
3 





Ruan et al.14 (150) 
Zhou et al.15 (191) 
Wu et al.16 (201)
100% - ↑ 0 0 3 NA ●●○
3 






Li et al.11 (84) 
Wang et al.7 (138) 
Zhang et al.6 (19) 
Ruan et al.14 (150) 
Zhou et al.15 (191)
100% - 
Presence
Huang et al.17 (41) 
Tang et al.13 (183)
Guan et al.18 
(1099) 
Yang et al.19 (52)
3 NA ●●○
8 






Huang et al.17 (41) 
Wang et al.7 (138) 
Liu et al.9 (109) 
Wu et al.16 (201)
75% - ↑ Liu et al.
10 (78) 
Li et al.11 (84)
Young et al.20 (18) 2 NA ●●○
7 
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Table. Summary of risk factors associated with covid-19 severity and evaluation of reporting consistency. Continuation
Creatine 
kinase MB
Wang et al.7 (138) 
Zhou et al.15 (191) 
Wu et al.16 (201)
100% - ↑ Liu et al.9 (109) 0 2 NA ●●○
4 





Liu et al.9 (109) 
Zhou et al.15 (191) 100% - ↑ 0 0 2 NA ●●○
2 







Huang et al.17 (41) 
Liu et al.10 (78) 
Tian et al.8 (262) 
Zhou et al.15 (191)
100% - ↑ Li et al.
11 (84) 
Wang et al.7 (138)
Young et al.20 (18) 2 NA ●●○
3 







Li et al.11 (84) 100% - ↓ 0 0 1 NA ●●○
1 







Liu et al.9 (109) 
Zhou et al.15 (191)
100% - 
Presence
Ruan et al.14 (150) 0 1 NA ●●○
3 





Chest pain Li et al.11 (84)
100% - 
Presence
0 Yang et al.19 (52) 1 NA ●●○
2 






Li et al.11 (84) 100% - ↑ 0 0 1 NA ●●○
1 








Tang et al.13 (183) 100% - ↑ 0 0 1 NA ●●○
1 




Myoglobin Ruan et al.14 (150) 100% - ↑ 0 0 1 NA ●●○
1 





APACHE II Liu et al.9 (109) 100% - ↑ 0 0 1 NA ●●○
1 
 (0/1) = 0% 
 
Median (IQR) 
APACHE II score, 
NA
PaO2:FiO2 Liu et al.9 (109) 100% - ↓ 0 0 1 NA ●●○
1 





Globulin Wu et al.16 (201) 100% - ↑ 0 0 1 NA ●●○
1 
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Table. Summary of risk factors associated with covid-19 severity and evaluation of reporting consistency. Continuation
Prealbumin Wu et al.16 (201) 100% - ↓ 0 0 1 NA ●●○
1 




Urea Wu et al.16 (201) 100% - ↑ 0 0 1 NA ●●○
1 




Glucose Wu et al.16 (201) 100% - ↑ 0 0 1 NA ●●○
1 




Cholinesterase Wu et al.16 (201) 100% - ↓ 0 0 1 NA ●●○
1 





Cystatin C Wu et al.16 (201) 100% - ↑ 0 0 1 NA ●●○
1 




α-HBDH Wu et al.16 (201) 100% - ↑ 0 0 1 NA ●●○
1 





LDL Wu et al.16 (201) 100% - ↓ 0 0 1 NA ●●○
1 




Heart Rate Zhou et al.15 (191) 100% - ↑ 0 0 1 NA ●●○
1 
 (0/1) = 0% 
 
Percentages 





Ji et al.21 (NA) 100% - ↑ 0 0 1 NA ●●○
1 








Li et al.11 (84) 
Wang et al.7 (138) 
Tian et al.8 (262)*
100% - ↑ Zhang et al.
6 (19) 
Zhou et al.15 (191)
Huang et al.17 (41) 1 NA ●●○
5 






O2 saturation Li et al.11 (84) 100% - ↓ Liu et al.10 (78) Young et al.20 (18) 0 NA ●●○
3 





Fibrinogen Liu et al.9 (109) 100% - ↑ Tang et al.13 (183) 0 0 NA ●●○
2 
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Table. Summary of risk factors associated with covid-19 severity and evaluation of reporting consistency. Continuation
Smoking Liu et al.10 (78)
100% - 
Presence
Huang et al.17 (41) 
Zhang et al.6 (19) 
Zhou et al.15 (191)
Guan et al.18 
(1099) 
Yang et al.19 (52)
-2
Liu et al.10  
Past use: OR 14.3 
 95% CI 1.6 - 25.0
●●○
5 








Caramelo et al.12 
(72314) 
Li et al.11 (84) 
Zhou et al.15 (191)
100% - 
Presence
Huang et al.17 (41) 
Zhang et al.6 (19) 
Wang et al.7 (138) 
Liu et al.10 (78) 
Liu et al.9 (109) 
Ruan et al.14 (150)
Yang et al.19 (52) 
Zhonghua22 
(44672) 
Guan et al.18 
(1099)
-3
Caramelo et al.12 
CRD: OR 7.8 
95% CI 5.5 - 10.4
●●○
10 









Huang et al.17 (41) 
Liu et al.10 (78) 
Ruan et al.14 (150) 
Zhou et al.15 (191)
Zhonghua22 
(44672) 
Guan et al.18 
(1099)
-3
Liu et al.10  
Cancer: OR 6.9 
 95% CI 3.4 - 12.5
●●○
7 






Caramelo et al.12 
(72314) 
Ruan et al.14 (150) 
Zhou et al.15 (191)
100% - 
Presence
Huang et al.17 (41) 
Wang et al.7 (138) 
Liu et al.9 (109) 
Zhang et al.6 (19)
Liu et al.10 (78) 
Li et al.11 (84) 
Wu et al.16 (201)
Guan et al.18 
(1099) 




Caramelo et al.12  
 HTA: OR 7.4  
95% CI 6.3 - 8.8 
 
 Cardiac: OR 12.8  
95% CI 10.3 - 15.9
●●○
12 





Lactate Liu et al.9 (109) 100% - ↑ 0 Yang et al.
19 (52) 
Wang et al.7 (138)
-1 NA ●○○
3 






Li et al.11 (84) 100% - ↓ Wang et al.
7 (138) 
Wu et al.16 (201)
0 -1 NA ●○○
3 






Ruan et al.14 (150) 
Wang et al.7 (138) 
Zhou et al.15 (191)
100% - ↑
Liu et al.10 (78) 
Huang et al.17 (41) 
Liu et al.9 (109) 
Wu et al.16 (201)
Yang et al.19 (52) 













Li et al.11 (84) 
Zhou et al.15 (191) 100% - ↑
Wang et al.7 (138) 
Zhang et al.6 (19) 
Huang et al.17 (41)
Young et al.20 (18) 










Huang et al.17 (41) 100% - ↑ Tian et al.
8 (262)* 
Zhou et al.15 (191)
Yang et al.19 (52) 
Young et al.20 (18)
-1 NA ●○○
2 







Ruan et al.14 (150) 
Zhou et al.15 (191) 100% - ↓
Wang et al.7 (138) 
Liu et al.10 (78) 
Wu et al.16 (201)
Yang et al.19 (52) 
Tang et al.13 (183) 
Young et al.20 (18) 
Guan et al.18 
(1099) 
Huang et al.17 (41)
-1 NA ●○○
5 
 (5/10) = 50% 
 
Median (IQR) 
Platelet count / 
×109/L
AST
Wang et al.7 (138) 
Wu et al.16 (201) 100% - ↑
Liu et al.10 (78) 
Liu et al.9 (109) 
Ruan et al.14 (150)
Guan et al.18 
(1099) 
Huang et al.17 (41)
-1 NA ●○○
6 
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performed multivariate analysis adjusting for confounding factors. Sixteen of the studies 
reported laboratory-confirmed cases of covid-19 and one reported clinically diagnosed 
cases. There were 60 risk factors identified for COVID-19 severity (Table). Of these, 7 were 
considered of high, 40 of medium and 13 of low consistency. Increasing values of age, 
D-dimer, C-reactive protein, sequential organ failure assessment (SOFA) score and body 
temperature while decreasing albumin, and a history of diabetes were the risk factors 
with the highest consistency as predictors for covid-19 severity. Additionally, elevated 
values of white blood cells count, procalcitonin, lactate dehydrogenase, cardiac troponins, 
prothrombin time, interleukin-6, serum ferritin, neutrophils count, creatine kinase MB, 
CURB-65 score with decreased lymphocyte count, and dyspnea were classified as medium 
consistency risk factors with at least a positive difference of two studies reporting a 
statistically significant difference between non-severe and CSF groups. There was high 
heterogeneity in the definition of CSF, ranging from the need for supplemental oxygen 
to the development of acute respiratory distress syndrome (ARDS), ICU admission and 
death. In terms of risk factor heterogeneity, 40% of factors presented a value of zero with 
an overall median of 14% (IQR = 0–25). Nevertheless, when considering only the remaining 
60% variables, the mean heterogeneity value was 28.5% (SD = 19.6).
DISCUSSION
The results from this review are consistent with current analyses considering age and 
comorbidities the most important risk factors for covid-19 disease severity. However, 
Table. Summary of risk factors associated with covid-19 severity and evaluation of reporting consistency. Continuation
ALT
Wang et al.7 (138) 
Huang et al.17 (41) 
Zhou et al.15 (191)
100% - ↑
Liu et al.10 (78) 
Liu et al.9 (109) 
Ruan et al.14 (150) 
Wu et al.16 (201)










Expectoration Li et al.11 (84)
100% - 
Presence
Wang et al.7 (138) 
Huang et al.17 (41) 
Ruan et al.14 (150) 
Zhou et al.15 (191)









Li et al.11 (84) 
Zhang et al.6 (19)
100% - 
Presence
Huang et al.17 (41)
Tian et al.8 (262) 
Wang et al.7 (138)
Liu et al.10 (78) 
Liu et al.9 (109) 
Ruan et al.14 (150) 
Zhou et al.15 (191) 
Wu et al.16 (201)
Yang et al.19 (52) 
Guan et al.18 
(1099) 
Young et al.20 (18)
-6 NA ●○○
11 




Fatigue Liu et al.9 (109)
100% - 
Presence
Huang et al.17 (41) 
Zhang et al.6 (19) 
Tian et al.8 (262) 
Wang et al.7 (138) 
Ruan et al.14 (150) 
Wu et al.16 (201) 
Zhou et al.15 (191)









Tang et al.13 (183) 




Huang et al.17 (41) 
Zhang et al.6 (19) 
Wang et al.7 (138) 
Tian et al.8 (262) 
Liu et al.9 (109) 
Li et al.11 (84) 
Ruan et al.14 (150) 
Liu et al.10 (78) 
Zhou et al.15 (191) 
Wu et al.16 (201)
Guan et al.18 
(1099) 
Yang et al.19 (52) 
Zhonghua22 
(44672) 
Young et al.20 (18)
-8 NA ●○○
15 




HTA: hypertension; CRD: chronic respiratory disease
* Data provided directly by the authors of the publication.
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our findings also suggest that diabetes is one of the most critical comorbidities in terms 
of disease severity. Diabetes has been previously associated with other respiratory 
virus disease severities in cross national samples5. This might be explained by the 
immunosuppressive effects of hyperglycaemia5 and could also explain why patients 
that develop ARDS due to covid-19 were found to have statistically significant higher 
glucose levels (Table). This finding has important implications given the high global 
prevalence of diabetes. When considering the heterogeneity of reported factors across 
studies, 60% presented some level of heterogeneity, which indicates that there is a 
need for higher reporting consistency in future research looking at the risk factors for 
covid-19 disease severity. 
Some limitations should be considered when interpreting these findings. Most of the 
selected studies were conducted in China (and one in Singapore), limiting the external 
validity of risk factors for other countries. As we used a composite index of severity, 
the relevance of these factors varies according to the natural history of the disease 
with some factors, such as body temperature and neutrophils count (and their value 
directions -higher/lower) being more relevant for different stages. A limitation of this 
study is the rapid growth of knowledge about covid-19. Therefore, the results of the present 
review might vary as the scientific understanding of covid-19 progresses. Additionally, 
two of the 17 studies reviewed were pre-prints (neither published, nor peer-reviewed). 
Despite this, the wide range of risk factors identified across 17 publications can guide 
future research to rapidly validate the present results on cross-national samples. 
Given that the burden to the health system due to covid-19 is a determinant of the disease 
severity (Table), the results from this review can support clinical and public health initiatives 
to target populations and patients that are at most risk while further evidence is generated. 
Additionally, the present review provides researchers with a rapid reference on reported 
clinical and demographical factors in order to increase the comparability of results and 
further decrease uncertainties regarding the covid-19 severity. This can support clinical 
management decisions and the design of strategies to inform the general public about 
important risk factors for covid-19 severity, For instance, when communicating who is 
most at risk for the disease, instead of making a broad generalization such as “increasing 
age and underlying health conditions,” messaging that communicates risk factors should 
at a minimum include: age > 50, diabetes, smoking, respiratory disease, cancer and 
cardiovascular disease. Additionally, for patients that are isolated outside a healthcare 
institution either due to clinical suspicion or confirmed mild case, specific factors such as 
shortness of breath and chest pain could be communicated as triggers for seeking care. 
Factors such as fatigue, cough and expectoration have low consistency for predicting disease 
severity and by themselves should not be relied upon for clinical assessment. We expect that 
the results of this brief review can support government and medical strategies in response 
to the pandemic. 
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